Aytu BioPharma

AYTU

NASDAQHealth Care

Income Statement

Total Revenue$61.41M

Gross Profit$44.18M

Operating Income$-6.5M

EBITDA$6.54M

EBIT$825K

Pre-tax Income$-24.24M

Net Income$-5.24M

Cash Equivalent$20.07M

Total Debt$16.06M

Book Value$29.77M

Book Value Per Share5.08

Return on Equity (ROE)-57.17%

Return on Assets (ROA)-13.42%

Return on Invested Capital (ROI)-36.98%

Net Profit Margin-19.56%

Current Ratio0.99

Quick Ratio0.70

Long-Term Debt / Equity0.39